A Comprehensive Visual Rating Scale for Predicting Progression from Mild Cognitive Impairment to Dementia in Patients with Alzheimer's Pathology or Suspected Non-Alzheimer's Pathology

키워드

참고문헌 (37)

1. Meles SK, "The Alzheimer's disease metabolic brain pattern in mild cognitive impairment", J Cereb Blood Flow Metab, 37, pp.3643~3648 (2017)
2. Huijbers W, "Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression", Brain, 138, pp.1023~1035 (2015)
3. Selkoe DJ, "The amyloid hypothesis of Alzheimer's disease at 25 years", EMBO Mol Med, 8, pp.595~608 (2016)
4. Winblad B, "Mild cognitive impairment--beyond controversies, towards a consensus : report of the International Working Group on Mild Cognitive Impairment", J Intern Med, 256, pp.240~246 (2004)
5. Beach TG, "Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010", J Neuropathol Exp Neurol, 71, pp.266~273 (2012)
6. Gamberger D, "Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer's disease", Sci Rep, 7, pp.6763~ (2017)
7. Hinrichs C, "Predictive markers for AD in a multi-modality framework : an analysis of MCI progression in the ADNI population", Neuroimage, 55, pp.574~589 (2011)
8. Jack CR Jr, "NIA-AA research framework : toward a biological definition of Alzheimer's disease", Alzheimers Dement, 14, pp.535~562 (2018)
9. Olsson B, "CSF and blood biomarkers for the diagnosis of Alzheimer's disease : a systematic review and meta-analysis", Lancet Neurol, 15, pp.673~684 (2016)
10. Murray ME, "Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics : a retrospective study", Lancet Neurol, 10, pp.785~796 (2011)
11. Jang JW, "A ‘comprehensive visual rating scale’for predicting progression to dementia in patients with mild cognitive impairment", PLoS One, 13, pp.e0201852~ (2018)
12. McKhann GM, "The diagnosis of dementia due to Alzheimer's disease : recommendations from the National Institute on AgingAlzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease", Alzheimers Dement, 7, pp.263~269 (2011)
13. Sperling RA, "Toward defining the preclinical stages of Alzheimer's disease : recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease", Alzheimers Dement, 7, pp.280~292 (2011)
14. Jack CR Jr, "Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease", Alzheimers Dement, 7, pp.257~262 (2011)
15. Jang JW, "A comprehensive visual rating scale of brain magnetic resonance imaging : application in elderly subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition", J Alzheimers Dis, 44, pp.1023~1034 (2015)
16. Wechsler D, "WMS-R : Wechsler Memory Scale--Revised Manual" (1987), Psychological Corp
17. Shaw LM, "Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects", Ann Neurol, 65, pp.403~413 (2009)
18. McKhann G, "Clinical diagnosis of Alzheimer's disease : report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease", Neurology, 34, pp.939~944 (1984)
19. Jack CR Jr, "A", T, Neurology, pp.2016, 87[DOI]
20. Jack CR Jr, "The Alzheimer's Disease Neuroimaging Initiative(ADNI) : MRI methods", J Magn Reson Imaging, 27, pp.685~691 (2008)
21. Fox J, "Generalized collinearity diagnostics", J Am Stat Assoc, 87, pp.178~183 (1992)
22. Therneau T, "A Package for Survival Analysis in R" (2020), R Foundation
23. Wickham H, "ggplot2 : Elegant Graphics for Data Analysis" (2009), Springer
24. Roberts RO, "Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal", Neurology, 82, pp.317~325 (2014)
25. Jack CR Jr, "Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease", Brain, 133, pp.3336~3348 (2010)
26. Pankratz VS, "Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging", Neurology, 84, pp.1433~1442 (2015)
27. Shen Q, "Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease", Alzheimers Dement, 7, pp.e101~e108 (2011)
28. Frisoni GB, "Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia", J Neurol Neurosurg Psychiatry, 69, pp.572~ (2000)
29. Bresciani L, "Visual assessment of medial temporal atrophy on MR films in Alzheimer's disease : comparison with volumetry", Aging Clin Exp Res, 17, pp.8~13 (2005)
30. Ekman U, "The A", T, Sci Rep, pp.2018, 8[DOI]
31. Maia LF, "Changes in amyloid-β and tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein", Sci Transl Med, 5, pp.194re2~ (2013)
32. Wallin A, "The Gothenburg MCI study : design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up", J Cereb Blood Flow Metab, 36, pp.114~131 (2016)
33. Barnes J, "Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls", Neurobiol Aging, 34, pp.1996~2002 (2013)
34. Fiford CM, "White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy", Hippocampus, 27, pp.249~262 (2017)
35. Ferreira D, "Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy : longitudinal trajectories and clinical applications", Sci Rep, 7, pp.46263~ (2017)
36. Jokinen H, "Incident lacunes influence cognitive decline : the LADIS study", Neurology, 76, pp.1872~1878 (2011)
37. Ikram MA, "The Rotterdam Scan Study : design update 2016 and main findings", Eur J Epidemiol, 30, pp.1299~1315 (2015)

관련 논문AI추천